González-Gil, Esther M.
Peruchet-Noray, Laia
Sedlmeier, Anja M.
Christakoudi, Sofia
Biessy, Carine
Navionis, Anne-Sophie
Mahamat-Saleh, Yahya
Jaafar, Rola F.
Baurecht, Hansjörg
Guevara, Marcela
Etxezarreta, Pilar Amiano
Verschuren, W. M. Monique
Boer, Jolanda M. A.
Olsen, Anja
Tjønneland, Anne
Simeon, Vittorio
Castro-Espin, Carlota
Aune, Dagfinn
Heath, Alicia K.
Gunter, Marc
Colorado-Yohar, Sandra M.
Zilhão, Nuno R.
Dahm, Christina C.
Llanaj, Erand
Schulze, Matthias B.
Petrova, Dafina
Sieri, Sabina
Ricceri, Fulvio
Masala, Giovanna
Key, Tim
Viallon, Vivian
Rinaldi, Sabina
Freisling, Heinz
Dossus, Laure
Article History
Received: 4 March 2024
Accepted: 29 July 2024
First Online: 15 August 2024
Declarations
:
: This study complies with the Declaration of Helsinki. EPIC was approved by the Ethics Committee of the International Agency for Research on Cancer (IARC) (ref IEC 14–02), Lyon, France, as well as the local ethics committees of the study centres. All participants provided written informed consent for data collection and storage as well as individual follow-up.The UK Biobank study was approved by the Northwest Multi-Centre Research Ethics Committee (reference for UK Biobank is 16/NW/0274) and all participants provided written informed consent to participate in the UK Biobank study. The study protocol is available online ().
: Not applicable.
: The authors declare no competing interests.